Neuropace Inc
NASDAQ:NPCE

Watchlist Manager
Neuropace Inc Logo
Neuropace Inc
NASDAQ:NPCE
Watchlist
Price: 14.09 USD -0.21% Market Closed
Market Cap: $466.1m

Neuropace Inc
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Neuropace Inc
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
Neuropace Inc
NASDAQ:NPCE
Other Items
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Other Items
-$1.8B
CAGR 3-Years
-7%
CAGR 5-Years
N/A
CAGR 10-Years
-1%
Edwards Lifesciences Corp
NYSE:EW
Other Items
-$452.7m
CAGR 3-Years
N/A
CAGR 5-Years
-30%
CAGR 10-Years
-8%
Stryker Corp
NYSE:SYK
Other Items
-$4.1B
CAGR 3-Years
-21%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Other Items
-$251m
CAGR 3-Years
N/A
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Intuitive Surgical Inc
NASDAQ:ISRG
Other Items
$1.2B
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Neuropace Inc
Glance View

NeuroPace, Inc. develops, manufactures and markets implantable devices for treating epilepsy and neurological disorders. The company is headquartered in Mountain View, California. The company went IPO on 2021-04-22. The firm is focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company’s novel and differentiated RNS System is the brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source. The Company’s RNS System is a platform that delivers care for patients suffering from drug-resistant epilepsy and offers a personalized solution and outcomes to the patients suffering from other brain disorders. RNS System is a device that records brain activity data and clinicians to monitor patients. RNS System monitors the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is engaged in treating other brain disorders including depression, impulse control disorders, memory disorders, and post-traumatic stress.

NPCE Intrinsic Value
6.11 USD
Overvaluation 57%
Intrinsic Value
Price

See Also

What is Neuropace Inc's Other Items?
Other Items
0 USD

Based on the financial report for Dec 31, 2025, Neuropace Inc's Other Items amounts to 0 USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett